Glenmark Pharma gets USFDA nod for generic drug

Glenmark Pharma gets USFDA nod for generic drug

The approval granted by the US Food & Drug Administration (USFDA) is for bicardipine hydrochloride capsules of strengths 20 mg and 30 mg, Glenmark said in a statement.

PTIUpdated: Monday, December 19, 2022, 01:19 PM IST
article-image
Glenmark Pharma gets USFDA nod for generic drug | Photo credit: Twitter

Glenmark Pharmaceuticals Ltd on Monday said it has received final approval from the US health regulator for its generic nicardipine hydrochloride capsules used to treat high blood pressure and to control angina.

The approval granted by the US Food & Drug Administration (USFDA) is for bicardipine hydrochloride capsules of strengths 20 mg and 30 mg, Glenmark said in an exchange filing.

These are the generic version of Cardene capsules 20 mg and 30 mg of Chiesi USA, Inc, it added.

These will be distributed in the US by Glenmark Pharmaceuticals Inc, USA, the company said.

For the 12-month period ended October 2022, the Cardene capsules 20 mg and 30 mg achieved annual sales of approximately USD 10.9 million, the company said citing IQVIATM sales data.

RECENT STORIES

Should India Brace Up For Lower GDP Growth Rate? CEA Says No; Outlines Risks & Measures From Trump's...

Should India Brace Up For Lower GDP Growth Rate? CEA Says No; Outlines Risks & Measures From Trump's...

Gold Falls ₹200 To ₹1,07,670/10 G, Silver Declines ₹1,000 In Delhi Markets

Gold Falls ₹200 To ₹1,07,670/10 G, Silver Declines ₹1,000 In Delhi Markets

Relief On Lending Rates, HDFC Bank Announces Fresh Rates For Borrowers

Relief On Lending Rates, HDFC Bank Announces Fresh Rates For Borrowers

Investors Cheer Price Revision Post GST, Auto Stocks In Action On Counters

Investors Cheer Price Revision Post GST, Auto Stocks In Action On Counters

IAS Officer Baldeo Purushartha Appointed Government Nominee Director On The Board Of Housing And...

IAS Officer Baldeo Purushartha Appointed Government Nominee Director On The Board Of Housing And...